VVX Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline Polaris Inc PII Q1 2026 Earnings Surprise Profit Turnaround as EPS Blows Past Estimates AVAH Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines Telomir Pharmaceuticals TELO Q4 2025 Earnings WiderthanExpected Loss Amid Ongoing Development SRL Q4 2009 Earnings Massive EPS Beat Amidst Unusual Reporting CTMX Q1 2026 Earnings Narrower Loss Exceeds Expectations as Pipeline Advances LUMN Q1 2026 Earnings Significant EPS Miss as Company Faces Ongoing Challenges Xeris Biopharma Holdings Inc XERS Q1 2026 Earnings EPS Surprise Turns Positive as Stock Dips ISTR Q1 2026 Earnings Strong EPS Beat Driven by Improved Margins and Loan Growth SCVL Q1 2026 Earnings EPS Beats Estimates Despite Revenue Headwinds Stock Declines MHLA Q3 2024 Earnings Underlying Company Reports Negative EPS No Revenue Data Available